Skip to main content
×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market

October 16, 2022
  • New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare’s immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials
  • Telix tracers evaluate levels of carbonic anhydrase IX and lactate in tumours to inform and improve therapy selection
  • GE Healthcare’s Pharmaceutical Diagnostics business is an established global supplier of PET imaging tracers to the global clinical research market

Melbourne (Australia) – 17 October 2022.


business unit
tags
Subscribe to Immuno-Diagnostics